This October, there's some encouraging news on the breast cancer front. Yes, there are new drugs in the pipeline and ongoing trials -- the same old, real progress, slow as usual. Until last week, that is, when there came a hint of meaningful change in the breast cancer community.
You should think before you pink, as you might before giving to any solicitor of charitable funds. But let's not argue about the color and the ribbon which was, 20 years ago, an emblem of openness about a disease that women were afraid to mention out loud.